Immunomodulation by intravenous omega‐3 fatty acid treatment in older subjects hospitalized for COVID‐19: A single‐blind randomized controlled trial

• Hildur Arnardottir,
• Sven‐Christian Pawelzik,
• Philip Sarajlic,
• Alessandro Quaranta,
• Johan Kolmert,
• Dorota Religa,
• Craig E. Wheelock,
• Magnus Bäck

Affiliations

Hildur Arnardottir

Department of Medicine Solna Karolinska Institutet Theme Heart, Vessels, and Neuro Karolinska University Hospital Stockholm Sweden

Sven‐Christian Pawelzik

Department of Medicine Solna Karolinska Institutet Theme Heart, Vessels, and Neuro Karolinska University Hospital Stockholm Sweden

Philip Sarajlic

Department of Medicine Solna Karolinska Institutet Theme Heart, Vessels, and Neuro Karolinska University Hospital Stockholm Sweden

Alessandro Quaranta

Division of Physiological Chemistry 2 Department of Medical Biochemistry and Biophysics Karolinska Institute Stockholm Sweden

Johan Kolmert

Division of Physiological Chemistry 2 Department of Medical Biochemistry and Biophysics Karolinska Institute Stockholm Sweden

Dorota Religa

Department of Neurobiology Karolinska Institutet and Theme Ageing Karolinska University Hospital Stockholm Sweden

Craig E. Wheelock

Division of Physiological Chemistry 2 Department of Medical Biochemistry and Biophysics Karolinska Institute Stockholm Sweden

Magnus Bäck

Department of Medicine Solna Karolinska Institutet Theme Heart, Vessels, and Neuro Karolinska University Hospital Stockholm Sweden